SF
| Title | Published in | Access level | OA Policy | Year | Views | Downloads | |
|---|---|---|---|---|---|---|---|
| Assessment of access and outcomes of kidney transplantation through the reforms of the Swiss organ allocation system | Frontiers in public health | 2025 | 115 | 52 | |||
| Reintegration Into the Workforce After Kidney Transplantation Based on Urbanization Status in Switzerland | Kidney International Reports | 2025 | 90 | 79 | |||
| Outcome of Patients Transplanted for C3 Glomerulopathy and Primary Immune Complex-Mediated Membranoproliferative Glomerulonephritis | Kidney international reports | 2025 | 36 | 26 | |||
| Surgical site infections, risk factors, and outcomes after liver transplant | JAMA network open | 2025 | 56 | 34 | |||
| Infectious disease events in people with HIV receiving kidney transplantation : Analysis of the Swiss HIV Cohort Study and the Swiss Transplant Cohort Study | BMC infectious diseases | 2024 | 60 | 71 | |||
| BK polyomavirus serotype-specific antibody responses in blood donors and kidney transplant recipients with and without new-onset BK polyomavirus-DNAemia : A Swiss Transplant Cohort Study | American journal of transplantation | 2024 | 44 | 71 | |||
| Surgical site infections after kidney transplantation are independently associated with graft loss | American journal of transplantation | 2024 | 43 | 61 | |||
| NK and T cell repertoire is established early after allogeneic HSCT and is profoundly imprinted by CMV reactivation | Blood advances | 2024 | 106 | 49 | |||
| Donation type and the effect of pre-transplant donor specific antibodies - Data from the Swiss Transplant Cohort Study | Frontiers in immunology | 2023 | 152 | 39 | |||
| CMV serostatus and T-cell repertoire diversity 5 years after allogeneic hematopoietic stem cell transplantation | Leukemia & lymphoma | 2023 | 71 | 34 | |||
| Clinical prediction model for prognosis in kidney transplant recipients (KIDMO) : study protocol | Diagnostic and prognostic research | 2023 | 72 | 92 | |||
| Antibody Response After the Third SARS-CoV-2 Vaccine in Solid Organ Transplant Recipients and People Living With HIV (COVERALL-2) | Open forum infectious diseases | 2023 | 83 | 50 | |||
| Antibody Response After Third Vaccination With mRNA-1273 or BNT162b2 : Extension of a Randomized Controlled SARS-CoV-2 Noninferiority Vaccine Trial in Patients With Different Levels of Immunosuppression (COVERALL-2) | Open forum infectious diseases | 2023 | 137 | 62 | |||
| HLA variants and TCR diversity against SARS-CoV-2 in the pre-COVID-19 era | HLA | 2023 | 97 | 73 | |||
| The impact of pre-transplant donor specific antibodies on the outcome of kidney transplantation – Data from the Swiss transplant cohort study | Frontiers in immunology | 2022 | 180 | 72 | |||
| Use of statins after liver transplantation is associated with improved survival: results of a nationwide study | Alimentary pharmacology & therapeutics | 2022 | 144 | 117 | |||
| Developing and testing a Corona VaccinE tRiAL pLatform (COVERALL) to study Covid-19 vaccine response in immunocompromised patients | BMC infectious diseases | 2022 | 138 | 64 | |||
| Epidemiology and outcomes of bone and joint infections in solid organ transplant recipients | American journal of transplantation | 2022 | 239 | 91 | |||
| Antibody Response in Immunocompromised Patients After the Administration of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Vaccine BNT162b2 or mRNA-1273: A Randomized Controlled Trial | Clinical infectious diseases | 2022 | 141 | 52 | |||
| Analysis of biological models to predict clinical outcomes based on HLA-DPB1 disparities in unrelated transplantation | Blood advances | 2021 | 310 | 105 | |||
| Infectious complications and graft outcome following treatment of acute antibody-mediated rejection after kidney transplantation: A nationwide cohort study | PLOS ONE | 2021 | 316 | 315 | |||
| Pre-transplant donor-specific HLA antibodies and risk for poor first-year renal transplant outcomes: results from the Swiss Transplant Cohort Study | Transplant international | 2021 | 245 | 279 | |||
| Genetic T-cell receptor diversity at 1 year following allogeneic hematopoietic stem cell transplantation | Leukemia | 2020 | 398 | 283 | |||
| Preformed and de novo DSA are associated with T-cell-mediated rejection in pediatric liver transplant recipients requiring clinically indicated liver biopsy | Pediatric Transplantation | 2020 | 406 | 2 | |||
| Peripheral donor specific antibodies are associated with histology and cellular subtypes in protocol liver biopsies of pediatric recipients | Transplantation | 2020 | 369 | 171 | |||
| High-resolution HLA phased haplotype frequencies to predict the success of unrelated donor searches and clinical outcome following hematopoietic stem cell transplantation | Bone Marrow Transplantation | 2019 | 448 | 117 | |||
| Identification of seven novel HLA class I and II alleles | HLA | 2018 | 248 | 0 | |||
| Clinical and histological evolution after de novo donor-specific anti-human leukocyte antigen antibodies: a single centre retrospective study | BMC Nephrology | 2018 | 548 | 193 | |||
| Factors associated with immune hemolytic anemia after pediatric liver transplantation | Pediatric Transplantation | 2018 | 377 | 1 | |||
| Donor-specific antibodies C1q-binding: improvement in kidney graft management? | Transplant international | 2017 | 479 | 0 | |||
| Structural Basis of Bone Fragility in Young Subjects with Inflammatory Bowel Disease: A High-resolution pQCT Study of the SWISS IBD Cohort (SIBDC) | Inflammatory Bowel Diseases | 2017 | 579 | 1 | |||
| Identification of 3 novel HLA-B alleles: B*08:173, B*18:72:03 and B*53:05:02 | HLA | 2017 | 550 | 0 | |||
| Immunogenicity of anti-HLA antibodies in pancreas and islet transplantation | Cell transplantation | 2016 | 549 | 3 | |||
| Analysis and monitoring of anti-HLA antibodies in solid-organ and stem cell transplantation : What to do? When should they be tested? | 2015 | 711 | 357 | ||||
| Kidney paired donation: a plea for a Swiss National Programme | Schweizerische medizinische Wochenschrift | 2015 | 714 | 298 | |||
| Late antibody-mediated rejection by de novo donor HLA-DP-specific antibody after renal transplantation: a case report | Human immunology | 2014 | 570 | 0 | |||
| Expression of killer cell immunoglobulin-like receptors (KIRs) by natural killer cells during acute CMV infection after kidney transplantation | Transplant immunology | 2014 | 689 | 2 | |||
| The clinical relevance of pre-formed anti-HLA and anti-MICA antibodies after cord blood transplantation in children | PloS one | 2013 | 721 | 386 | |||
| Effects of an Interleukin-15 Antagonist on Systemic and Skeletal Alterations in Mice with DSS-Induced Colitis | The American journal of pathology | 2013 | 554 | 0 | |||
| HLA and non-HLA polymorphisms in renal transplantation | Schweizerische medizinische Wochenschrift | 2012 | 659 | 1 | |||
| Posttransplant cellular immune reactivity against donor antigen correlates with clinical islet transplantation outcome: towards a better posttransplant monitoring | Cell transplantation | 2012 | 606 | 0 | |||
| Detection of anti-HLA antibodies by solid-phase assay in kidney transplantation: friend or foe? | Tissue antigens | 2012 | 696 | 0 | |||
| Contact with stimulated T cells up-regulates expression of peptidylarginine deiminase 2 and 4 by human monocytes | European cytokine network | 2012 | 577 | 0 | |||
| Do RANKL inhibitors (denosumab) affect inflammation and immunity? | Osteoporosis international | 2011 | 696 | 810 | |||
| Eculizumab in acute recurrence of thrombotic microangiopathy after renal transplantation | American journal of transplantation | 2011 | 738 | 0 | |||
| De novo anti-HLA antibody after pandemic H1N1 and seasonal influenza immunization in kidney transplant recipients | American journal of transplantation | 2011 | 662 | 0 | |||
| Donor-specific antibody levels and three generations of crossmatches to predict antibody-mediated rejection in kidney transplantation | Transplantation | 2010 | 653 | 0 | |||
| Early relapse of autoimmune glomerulonephritis after kidney transplantation despite antibody induction and triple-drug-based immunosuppression | Transplantation | 2010 | 651 | 0 | |||
| Natural killer cell receptor--repertoire and functions after induction therapy by polyclonal rabbit anti-thymocyte globulin in unsensitized kidney transplant recipients | Clinical immunology | 2010 | 644 | 0 | |||
| RANKing bone resorption versus inflammation: Infection makes the decision | IBMS boneKEy | 2010 | 523 | 312 | |||
| Inhibition of T cell-dependent and RANKL-dependent osteoclastogenic processes associated with high levels of bone mass in interleukin-15 receptor-deficient mice | Arthritis and rheumatism | 2010 | 532 | 0 | |||
| Neural progenitors derived from human embryonic stem cells are targeted by allogeneic T and natural killer cells | Journal of Cellular and Molecular Medicine | 2009 | 604 | 123 | |||
| Humoral and cellular rejection after combined liver-kidney transplantation in low immunologic risk recipients | Transplant international | 2009 | 635 | 0 | |||
| Long-term insulin-independence after allogeneic islet transplantation for type 1 diabetes: over the 10-year mark | American journal of transplantation | 2009 | 973 | 6 | |||
| In vivo investigations on anti-fibrotic potential of proteasome inhibition in lung and skin fibrosis | American journal of respiratory cell and molecular biology | 2008 | 757 | 1 | |||
| Low risk of anti-human leukocyte antigen antibody sensitization after combined kidney and islet transplantation | Transplantation | 2008 | 909 | 0 | |||
| Natural killer cell receptor repertoire and their ligands, and the risk of CMV infection after kidney transplantation | American journal of transplantation | 2008 | 765 | 0 | |||
| Prostaglandin E2 synergistically with interleukin-23 favors human Th17 expansion | Blood | 2008 | 593 | 0 | |||
| IL-21 promotes survival and maintains a naive phenotype in human CD4+ T lymphocytes | International immunology | 2008 | 571 | 164 | |||
| The proinflammatory cytokines IL-2, IL-15 and IL-21 modulate the repertoire of mature human natural killer cell receptors | Arthritis Research and Therapy | 2007 | 235 | 140 | |||
| Airway epithelial IL-15 transforms monocytes into dendritic cells | American journal of respiratory cell and molecular biology | 2007 | 614 | 1 | |||
| Anti-HLA antibody repertoire after IVIg infusion in highly sensitized patients waiting for kidney transplantation | Schweizerische medizinische Wochenschrift | 2006 | 520 | 319 | |||
| Acute humoral rejection in kidney allograft following a third-party arterial transplantation | American journal of transplantation | 2006 | 626 | 0 |
